NCT04052438View on ClinicalTrials.gov

PREDICTIVE IMMUNOLOGICAL STUDY OF RECURRENT ABORTIONS AND IMPLANTATION FAILURE

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
Maternal-Fetal KIR-HLA-C Compatibility
Interventions
DIAGNOSTIC_TEST

HLA-C and KIR determination for patients, couples, oocyte or semen donors, abortive tissue and newborn.

All Listed Sponsors
lead

IVI Madrid

OTHER

NCT04052438 - PREDICTIVE IMMUNOLOGICAL STUDY OF RECURRENT ABORTIONS AND IMPLANTATION FAILURE | Biotech Hunter | Biotech Hunter